Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

An Eμ-BCL-2 transgene facilitates leukaemogenesis by ionizing radiation

Abstract

Clonogenic murine B cell precursors are normally ultra-sensitive to apoptosis following genotoxic exposure in vitro but can be protected by expression of an Eμ-BCL-2 transgene. Such exposures are likely to be mutagenic. This in turn suggests that a level of in vivo genotoxic exposure that usually has minimal pathological consequences might become leukaemogenic when damaged cells fail to abort by apoptosis. If this were to be the case, then the cell type that becomes leukaemic and the chromosomal/molecular changes that occur would also be of considerable interest. We tested this possibility by exposing Eμ-BCL-2 and wild-type mice of differing ages to a single dose of X-irradiation of 1 – 4 Gy. Young (4 – 6 weeks) transgenic mice developed leukaemia at a high rate following exposure to 2 Gy but adult mice (4 – 6 months) did not. Exposure to 4 Gy produced leukaemia in both young and adult transgenic mice but at a higher frequency in the former. Leukaemic cell populations showed clonal rearrangements of the IGH gene but in most cases analysed had immunophenotypic features of an early B lympho-myeloid progenitor population which has not previously been recorded in radiation leukaemogenesis. Molecular cytogenetic analysis of leukaemic cells by banded karyotype and FISH revealed a consistent double abnormality: trisomy 15 plus an interstitial deletion of chromosome 4 that was confirmed by LOH analysis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Alexander BJ, Rasko JEJ, Morahan G and Cook WD. . 1995 Leukemia 9: 2009–2015.

  • Boice JDJ and Inskip PD. . 1996 In: Leukaemia. Henderson ES, Lister TA and Greaves MF (eds).. WB Saunders Company pp. 195–209.

    Google Scholar 

  • Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie AH. . 1993 Nature 362: 849–852.

  • Doll R and Wakeford R. . 1997 Br. J. Radiol. 70: 130–139.

  • Domen J, Gandy KL and Weissman IL. . 1998 Blood 91: 2272–2282.

  • Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Butel JS and Bradley A. . 1992 Nature 356: 215–221.

  • Fennelly J, Wright E and Plumb M. . 1997 Leukemia 11: 807–810.

  • Fisher DE. . 1994 Cell 78: 539–542.

  • Ford AM, Bennett CA, Healy LE, Navarro E, Spooncer E and Greaves MF. . 1992 Proc. Natl. Acad. Sci. USA 89: 3424–3428.

  • Ford AM, Watt SM, Furley AJW, Molgaard HV and Greaves MF. . 1988 EMBO J. 7: 2393–2399.

  • Greaves MF. . 1986 Science 234: 697–704.

  • Greaves MF. . 1997 Lancet 349: 344–349.

  • Griffiths SD, Clarke AR, Healy LE, Ross G, Ford AM, Hooper ML, Wyllie AH and Greaves M. . 1997 Oncogene 14: 523–531.

  • Griffiths SD, Goodhead DT, Marsden SJ, Wright EG, Krajewski S, Reed JC, Korsmeyer SJ and Greaves M. . 1994a J. Exp. Med. 179: 1789–1797.

  • Griffiths SD, Marsden SJ, Wright EG, Greaves MF and Goodhead DT. . 1994b Int. J. Radiat. Biol. 66: 197–205.

  • Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT and Weinberg RA. . 1994 Curr. Biol. 4: 1–7.

  • Ji W, Qu G-Z, Ye P, Zhang X-Y, Halabi S and Ehrlich M. . 1995 Cancer Res. 55: 2876–2882.

  • Kemp CJ, Wheldon T and Balmain A. . 1994 Nature Genet. 8: 66–69.

  • Koyama M, Ishihara K, Karasuyama H, Cordell JL, Iwamoto A and Nakamura T. . 1997 Int. J. Immunol. 9: 1767–1772.

  • Kuerbitz SJ, Plunkett BS, Walsh WV and Kastan MB. . 1992 Proc. Natl. Acad. Sci. USA 89: 7491–7495.

  • Liu Y, Hernandez AM, Shibata D and Cortopassi GA. . 1994 Proc. Natl. Acad. Sci. USA 91: 8910–8914.

  • Major IR and Mole RH. . 1978 Nature 272: 455–456.

  • Malumbres M, Perez de Castro I, Santos J, Melendez B, Mangues R, Serrano M, Pellicer A and Fernandez-Piqueras J. . 1997 Oncogene 14: 1361–1370.

  • McDonnell TJ, Deane N, Platt FM, Nunez G, Jaeger U, McKearn JP and Korsmeyer SJ. . 1989 Cell 57: 79–88.

  • McDonnell TJ and Korsmeyer SJ. . 1991 Nature 349: 254–256.

  • Merino R, Ding L, Veis DJ, Korsmeyer SJ and Nuñez G. . 1994 EMBO J. 13: 683–691.

  • Nishii K, Gibbons DL, Titley I, Papworth D, Goodhead DT and Greaves M. . 1998 Cell Death Diff. 5: 77–86.

  • Nuñez G, Merino R, Grillot D and González-García M. . 1994 Immunol. Today 15: 582–588.

  • Osmond DG. . 1993 Immunol. Today 14: 34–37.

  • Paulovich AG, Toczyski DP and Hartwell LH. . 1997 Cell 88: 315–321.

  • Purdie CA, Harrison DJ, Peter A, Dobbie L, White S, Howie SEM, Salter DM, Bird CC, Wyllie AH, Hooper ML and Clarke AR. . 1994 Oncogene 9: 603–609.

  • Santos J, Perez de Castro I, Herranz M, Pellicer A and Fernandez-Piqueras J. . 1996 Oncogene 12: 669–676.

  • Strasser A, Elefanty AG, Harris AW and Cory S. . 1996 EMBO J. 15: 3823–3834.

  • Strasser A, Harris AW, Bath ML and Cory S. . 1990 Nature 348: 331–333.

  • Strasser A, Harris AW and Cory S. . 1993 Oncogene 8: 1–9.

  • Upton AC, Wolff FF, Furth J and Kimball AW. . 1958 Cancer Res. 18: 842–848.

  • Vaux DL, Cory S and Adams JM. . 1988 Nature 335: 440–442.

  • Wiener F, Ohno S, Spira J, Haran-Ghere N and Klein G. . 1978 Nature 275: 658–660.

  • Yang E and Korsmeyer SJ. . 1996 Blood 88: 386–401.

  • Zhuang S-M, Schippert A, Haugen-Strano A, Wiseman RW and Söderkvist . 1998 Oncogene 16: 803–808.

Download references

Acknowledgements

This work was supported by the Leukaemia Research Fund, Medical Research Council and UK Co-ordinating Committee on Cancer Research (Radiation Programme). We thank Drs Koyama and de Fongeralles for providing antibodies, Dr Stan Korsmeyer for BCL-2 transgenic breeding stock, Ms Lyn Healy for technical support and Ms Barbara Deverson for help in preparation of the manuscript.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gibbons, D., MacDonald, D., McCarthy, K. et al. An Eμ-BCL-2 transgene facilitates leukaemogenesis by ionizing radiation. Oncogene 18, 3870–3877 (1999). https://doi.org/10.1038/sj.onc.1202721

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202721

Keywords

This article is cited by

Search

Quick links